
AI Sales Rep - Your Next Salesperson Might Not Be A Person at All
Identify and Influence Your Engaged Website Visitors into Sales-Ready Leads – Before You Commit a Single Working Hour.
Lower Funnel, Higher Value Leads: Using our advanced WebID +Person identification technology, we uncover and identify the most engaged visitors to your site. These are the prospects we focus on, ensuring maximum impact for your sales efforts.
- Detailed Prospect Data: We gather 40 points of data about each prospect, including first name, last name, email address, and more.
- Engaged, But Anonymous: These prospects are conducting online research but haven’t met with your sales team yet.
- Crucial Sales Funnel Position: These visitors are deep in your sales funnel, spending time on your key ‘buying pages’ but remaining unknown to you. They are the ones most likely to convert into appointments.
- AI-Driven Engagement: Our AI Sales Rep identifies and gently engages with these visitors, influencing them to express interest. The process is fully automated, so your sales team only needs to engage with the interested leads—your low-hanging fruit.
Leverage the power of AI to turn your website visitors into meeting-ready leads effortlessly.
Learn more
FrameworkLTC's fully integrated and scalable platform automates all manual tasks, allowing LTC pharmacies to focus on what is most important: improving patient lives. Automation replaces manual tasks and allows you to expand your business while maximising margins. Delivering services that meet the needs of each facility will strengthen your partner relationships. Our facility-centric software allows you to provide concierge-level service, catering to every patient, wing, and facility. Allow facilities to print bills, check order statuses, and process returns according to your pre-defined rules. Your facilities will appreciate your reports. Automate refill and reorder prescriptions so they don't get lost on the production floor.
Learn more
Amazon Bio Discovery
Amazon Bio Discovery is an innovative application leveraging AI to enhance the efficiency of early-stage drug discovery by fusing computational biology models with practical laboratory testing in a cohesive "lab-in-the-loop" approach. This tool empowers researchers by granting them immediate access to an extensive library of biological foundation models developed from vast biological datasets, facilitating the rapid generation and assessment of potential drug candidates, including antibodies, with improved accuracy and speed. Additionally, the platform features an integrated AI agent that allows users to engage in natural language conversations to choose suitable models, set up experiments, and fine-tune inputs, eliminating the need for advanced programming skills or complex infrastructure. Researchers can also create multi-step workflows that integrate various models, evaluate their efficacy, and share workflows among teams, thereby fostering better collaboration between computational biologists and laboratory scientists. Ultimately, this powerful tool aims to streamline the drug discovery process and enhance scientific innovation in the field.
Learn more
BenevolentAI
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Learn more